Patients with  a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest study examining its use in a community setting has found. CAR-T is shorthand for chimeric antigen receptor therapy. In this treatment,...

Blood cancer patients of all races who receive cord blood transplants are now living longer. The finding, reported by a team led by oncologist Dr. Karen Ballen, of UVA (University of Virginia) Health, shows that a previously...

Clinical trials sponsored by Big Pharma enrolled eight times as many patients as U.S.-government trials did between 2018 and 2022, new research shows. The study — conducted by researchers at Fred Hutch Cancer Center in Seattle —...

A new test called CheekAge, based on a quick swab of cells in the mouth, might someday be used to predict how long a person has to live, developers report. The test tracks what are known as...